Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like BioDelivery Provides Corporate Update And Reports Fourth Quarter And Full-Year 2016 Financial Results March 16, 2017 <b>Rhodes College</b> Unveils New $34 Million Cutting-Edge Science Facility August 31, 2017 CohBar Announces Second Quarter 2017 Financial Results August 14, 2017
BioDelivery Provides Corporate Update And Reports Fourth Quarter And Full-Year 2016 Financial Results March 16, 2017